US Broker Ratings

Savara, Inc. (SVRA) Investor Outlook: An 81% Upside Potential in Rare Respiratory Disease Treatment

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is capturing investor attention with its focus on rare respiratory diseases and a promising 81% potential upside. Operating within the biotechnology sector,..

AbCellera Biologics Inc. (ABCL) Investor Outlook: Analyzing the 155% Upside Potential

AbCellera Biologics Inc. (NASDAQ: ABCL) is currently capturing the attention of investors with its significant potential upside, as indicated by a 155.34% increase potential based on analyst target price ranges...

Fulgent Genetics, Inc. (FLGT) Investor Outlook: Exploring a 35.97% Potential Upside in the Healthcare Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a significant potential upside of 35.97%, the company presents a..

Vir Biotechnology, Inc. (VIR) Stock Analysis: An Investor’s Look at a Potential 116.98% Upside

Vir Biotechnology, Inc. (NASDAQ: VIR) is catching the eye of investors with a staggering potential upside of 116.98%, making it a compelling subject in the biotechnology sector. As a clinical-stage..

Sionna Therapeutics, Inc. (SION) Stock Analysis: A Promising 24% Upside Potential in the Biotech Arena

Sionna Therapeutics, Inc. (SION) is a clinical-stage biopharmaceutical company making waves in the healthcare sector, specifically within the biotechnology industry. With its primary focus on developing innovative treatments for cystic..

ArriVent BioPharma, Inc. (AVBP): Investor Outlook with a Promising 73% Potential Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a dynamic player in the biotechnology industry, is capturing investor attention with a compelling potential upside of 73.29%. This clinical-stage biopharmaceutical company, based in Newtown..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Unveiling an 87% Potential Upside in Gene Editing Innovation

Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of innovation in the biotechnology sector, focusing on groundbreaking genome editing treatments. As a clinical-stage company, Intellia’s ambitious pipeline aims to..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Exploring 113.62% Potential Upside with Strong Buy Ratings

For investors seeking opportunities in the biotechnology sector, Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) presents a compelling case with its significant upside potential and promising pipeline. With a current market..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Promising 87% Potential Upside Captures Investor Attention

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is drawing significant attention in the biotechnology sector, primarily due to a compelling potential upside of 87.03% based on current analyst ratings. Specializing in the..

CorMedix Inc. (CRMD): Investor Outlook with a Promising 102% Upside Potential

CorMedix Inc. (NASDAQ: CRMD) is capturing investor attention with its substantial growth trajectory and impressive potential upside. As a biopharmaceutical company operating in the biotechnology sector, CorMedix is making significant..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating the Healthcare Sector with a Promising 54.9% Revenue Growth

Avadel Pharmaceuticals plc (NASDAQ: AVDL), a prominent player in the healthcare sector, operates within the specialized niche of drug manufacturing, focusing on both specialty and generic pharmaceuticals. Headquartered in Dublin,..

SI-BONE, Inc. (SIBN) Stock Analysis: Strong Buy Ratings Signal 57.73% Potential Upside

SI-BONE, Inc. (NASDAQ: SIBN), a pioneering force in the medical devices sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry. Based in Santa Clara, California, SI-BONE..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring a 111% Potential Upside in Biotech Innovation

Gyre Therapeutics, Inc. (GYRE), a dynamic player in the biotechnology sector, is drawing attention from investors with its promising pipeline of anti-inflammatory and anti-fibrotic therapies. Headquartered in San Diego, California,..

PAR Technology Corporation (PAR): Investor Outlook Highlights a Potential 184% Upside

For investors seeking high-growth opportunities within the technology sector, PAR Technology Corporation (NYSE: PAR) presents an intriguing case. With its focus on omnichannel cloud-based hardware and software solutions, PAR is..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Exploring a 44.57% Potential Upside in the Digital Advertising Sector

DoubleVerify Holdings, Inc. (NYSE: DV), a key player in the Communication Services sector, operates within the Advertising Agencies industry with a focus on enhancing the effectiveness and quality of digital..

Paycom Software, Inc. (PAYC) Investor Outlook: Exploring the 22% Potential Upside

Investors interested in the technology sector may find Paycom Software, Inc. (NASDAQ: PAYC) an intriguing opportunity, particularly given its potential upside of 22% based on current analyst ratings. This cloud-based..

Intapp, Inc. (INTA) Stock Analysis: Exploring a 97% Upside Potential in AI-Powered Solutions

Intapp, Inc. (Nasdaq: INTA), a notable player in the software application industry, presents an intriguing investment opportunity, particularly for investors keen on the transformative potential of AI-powered solutions. With a..

RingCentral, Inc. (RNG) Investor Outlook: Analyzing Growth Potential with a Forward P/E of 6.53

RingCentral, Inc. (NYSE: RNG) is a prominent player in the Technology sector, specializing in software applications that revolutionize business communications. With a market capitalization of $2.98 billion, this U.S.-based company..

HubSpot, Inc. (HUBS) Stock Analysis: Navigating a 52.52% Potential Upside

HubSpot, Inc. (NYSE: HUBS) remains a compelling story for investors seeking exposure in the technology sector, particularly within the software application industry. The company, which boasts a market capitalization of..

Freshworks Inc. (FRSH) Stock Analysis: Exploring a 72.68% Potential Upside Amid Software Sector Growth

As Freshworks Inc. (NASDAQ: FRSH) continues to navigate the dynamic landscape of the technology sector, individual investors have much to consider. This application software company, headquartered in San Mateo, California,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds